USANA Health Sciences USNA Operating lease right-of-use assets amortization expense
Operating lease right-of-use assets amortization expense at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's operating lease right-of-use assets amortization expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is USANA Health Sciences's operating lease right-of-use assets amortization expense?
- USANA Health Sciences (USNA) reported operating lease right-of-use assets amortization expense of $1.51M in Q1 2026.
- How has USANA Health Sciences's operating lease right-of-use assets amortization expense changed year-over-year?
- USANA Health Sciences's operating lease right-of-use assets amortization expense decreased by 20.7% year-over-year, from $1.91M to $1.51M.
- What is the long-term trend for USANA Health Sciences's operating lease right-of-use assets amortization expense?
- Over 4 years (2021 to 2025), USANA Health Sciences's operating lease right-of-use assets amortization expense has grown at a -6.0% compound annual growth rate (CAGR), from $9.16M to $7.14M.
- What does operating lease right-of-use assets amortization expense mean?
- Represents the non-cash expense recognized over the lease term to amortize the right-of-use asset created under operating lease agreements. This metric reflects the systematic consumption of the economic benefits derived from leased properties or equipment. It is a key component in reconciling net income to cash flow from operations.